Quality, accuracy and professionalism you can rely upon.

BioKinetic Europe is as committed to your success as you are. As an independent, flexible Phase 1 clinical pharmacology company made up of talented, dedicated professionals, we have the right approach and experience to help you achieve that success. Our aim: to guarantee that you receive a cost-effective service, on time and within budget.

BioKinetic Europe has successfully completed studies for many international companies, covering a wide range of therapeutic areas. Our Most recent successful MHRA GCP and GMP inspections were conducted in April 2009.

The exceptionally favorable UK Regulatory environment, with the Phase 1 CTA approval timeline being 14 days, provides our clients with an added incentive to work with BioKinetic Europe. We also have a robust and active database of over 11,500 volunteers.

All studies are conducted to the most rigorous standards in accordance with the International Conference on Harmonisation Good Clinical Practice guidelines and the European Clinical Trials Directive. Our Quality Assurance and Quality Control systems are models of best practice, ensuring exceptional accuracy and efficiency.

BioKinetic Europe staff bring together years of expertise in the field gathered in the UK and the USA. This professionalism, together with a personal, approachable manner, ensures good working relationships with clients and volunteers alike.